CA2431313A1 - Procede de diagnostic du cancer du sein et/ou du cancer colorectal, compositions, et procedes de criblage de modulateurs du cancer du sein et/ou du cancer colorectal - Google Patents
Procede de diagnostic du cancer du sein et/ou du cancer colorectal, compositions, et procedes de criblage de modulateurs du cancer du sein et/ou du cancer colorectal Download PDFInfo
- Publication number
- CA2431313A1 CA2431313A1 CA002431313A CA2431313A CA2431313A1 CA 2431313 A1 CA2431313 A1 CA 2431313A1 CA 002431313 A CA002431313 A CA 002431313A CA 2431313 A CA2431313 A CA 2431313A CA 2431313 A1 CA2431313 A1 CA 2431313A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- differentially expressed
- antibody
- cha4
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
L'invention concerne des procédés utiles dans le diagnostic et le pronostic du cancer de sein et/ou du cancer colorectal. L'invention concerne également des procédés utiles dans le criblage d'agents bio-actifs candidats pour ce qui est de leur capacité à moduler le cancer de sein et/ou le cancer colorectal. Elle concerne, en outre, des procédés et des cibles moléculaires (des gènes et leurs produits) utilisés lors d'interventions thérapeutiques sur le cancer du sein et/ou le cancer colorectal.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/733,756 US20030198951A1 (en) | 1999-12-02 | 2000-12-08 | Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| US09/733,756 | 2000-12-08 | ||
| US09/733,757 | 2000-12-08 | ||
| US09/733,757 US20020102544A1 (en) | 2000-09-15 | 2000-12-08 | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
| PCT/US2001/048368 WO2002059609A2 (fr) | 2000-12-08 | 2001-12-10 | Procede de diagnostic du cancer du sein et/ou du cancer colorectal, compositions, et procedes de criblage de modulateurs du cancer du sein et/ou du cancer colorectal |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2431313A1 true CA2431313A1 (fr) | 2002-08-01 |
Family
ID=27112622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002431313A Abandoned CA2431313A1 (fr) | 2000-12-08 | 2001-12-10 | Procede de diagnostic du cancer du sein et/ou du cancer colorectal, compositions, et procedes de criblage de modulateurs du cancer du sein et/ou du cancer colorectal |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1410035A2 (fr) |
| JP (1) | JP2005506514A (fr) |
| CA (1) | CA2431313A1 (fr) |
| MX (1) | MXPA03005004A (fr) |
| WO (1) | WO2002059609A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0713098A2 (pt) * | 2006-05-22 | 2012-10-16 | Clinical Genomics Pty Ltd | método para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, método de detecção para determinar a origem anatÈmica de uma célula ou população celular derivada do intestino grosso de um indivìduo, sistema de detecção, meio de armazenagem legìvel por computador, arranjo de ácido nucleico, uso de um arranjo, método para determinar o inìcio ou predisposição para o inìcio de uma anormalidade celular ou uma condição destinguida por uma anormalidade celular no intestino grosso, kit de diagnóstico para ensaiar amostras biológicas |
| PL2567707T3 (pl) * | 2007-07-27 | 2017-03-31 | Immatics Biotechnologies Gmbh | Kompozycja peptydów związanych z guzem i pokrewna szczepionka przeciw rakowi |
| EA018456B1 (ru) | 2007-07-27 | 2013-08-30 | Имматикс Байотекнолоджиз Гмбх | Новые иммуногенные эпитопы для иммунотерапии |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69925024T2 (de) * | 1998-11-20 | 2006-03-02 | Genentech, Inc., South San Francisco | Verwendung von eph-rezeptor-antagonisten und agonisten zur behandlung von vaskulären krankheiten |
| AU2001264559A1 (en) * | 2000-06-05 | 2001-12-17 | Avalon Pharmaceuticals | Cancer gene determination and therapeutic screening using signature gene sets |
-
2001
- 2001-12-10 WO PCT/US2001/048368 patent/WO2002059609A2/fr not_active Application Discontinuation
- 2001-12-10 CA CA002431313A patent/CA2431313A1/fr not_active Abandoned
- 2001-12-10 MX MXPA03005004A patent/MXPA03005004A/es unknown
- 2001-12-10 EP EP01994241A patent/EP1410035A2/fr not_active Withdrawn
- 2001-12-10 JP JP2002559675A patent/JP2005506514A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| MXPA03005004A (es) | 2004-09-10 |
| JP2005506514A (ja) | 2005-03-03 |
| EP1410035A2 (fr) | 2004-04-21 |
| WO2002059609A3 (fr) | 2004-02-12 |
| WO2002059609A2 (fr) | 2002-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6682890B2 (en) | Methods of diagnosing and determining prognosis of colorectal cancer | |
| US6750013B2 (en) | Methods for detection and diagnosing of breast cancer | |
| US20020019330A1 (en) | Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators | |
| US6762020B1 (en) | Methods of diagnosing breast cancer | |
| JP2005503760A (ja) | 乳癌の診断方法、組成物および乳癌のモジュレーターのスクリーニング方法 | |
| CA2368152A1 (fr) | Nouvelles techniques permettant de traiter et de diagnostiquer le cancer du sein, compositions et techniques de criblage pour modulateurs de cancer du sein | |
| WO2000055633A9 (fr) | Methodes permettant de diagnostiquer du cancer colo-rectal, compositions, et methodes permettant de detecter des modulateurs du cancer colo-rectal | |
| US20030077568A1 (en) | Methods of diagnosis of colorectal cancer, compositions and methods of screening for colorectal cancer modulators | |
| US20020015970A1 (en) | Novel methods of diagnosis of angiogenesis, compositions, and methods of screening for angiogenesis modulators | |
| US6455668B1 (en) | Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
| US6294343B1 (en) | Methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
| US20020068036A1 (en) | Novel methods of diagnosis of prostate cancer and/or breast cancer, compositions, and methods of screening for prostate cancer and /or breast cancer modulators | |
| US6780586B1 (en) | Methods of diagnosing breast cancer | |
| US6773878B1 (en) | Methods of diagnosing of colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
| US6649342B1 (en) | Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | |
| US20030108926A1 (en) | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | |
| US20020076707A1 (en) | Novel methods of diagnosing cancer, compositions, and methods of screening for cancer modulators | |
| WO2002016939A2 (fr) | Procedes de diagnostic du cancer, compositions et procedes de depistage de modulateurs du cancer | |
| US6566502B1 (en) | Methods of diagnosing cancer, compositions, and methods of screening for cancer modulators | |
| US20040009494A1 (en) | Novel methods of diagnosis of angiogenesis and other conditions, compositions, and the methods of screening for modulators | |
| US20030157544A1 (en) | Novel methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators | |
| US20030198951A1 (en) | Novel methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators | |
| CA2431313A1 (fr) | Procede de diagnostic du cancer du sein et/ou du cancer colorectal, compositions, et procedes de criblage de modulateurs du cancer du sein et/ou du cancer colorectal | |
| US20030087245A1 (en) | Uses of PBH1 in the diagnosis and therapeutic treatment of prostate cancer | |
| US20020102544A1 (en) | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Dead |